Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
8,758
Total Claims
$1.6M
Drug Cost
691
Beneficiaries
$2,341
Cost/Patient
Risk Score Breakdown 9/100
Score components are additive. Read full methodology
Peer Comparison vs. 18,720 Cardiology providers
+54%
Cost per patient vs peers
$2,341 vs $1,524 avg
+34%
Brand preference vs peers
18.3% vs 13.7% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
0.8%
Opioid Rate
67
Opioid Claims
$4,871
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 1,602 claims · $1.4M
Generic: 7,136 claims · $241K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 456 | $486K |
| Rivaroxaban | 120 | $139K |
| Evolocumab | 131 | $108K |
| Empagliflozin | 58 | $75K |
| Dronedarone Hcl | 44 | $71K |
| Ticagrelor | 66 | $61K |
| Sacubitril/Valsartan | 50 | $54K |
| Sitagliptin Phosphate | 23 | $26K |
| Azilsartan Medoxomil | 46 | $25K |
| Sitagliptin Phos/Metformin Hcl | 17 | $24K |
| Semaglutide | 23 | $22K |
| Azilsartan Med/Chlorthalidone | 35 | $19K |
| Nebivolol Hcl | 211 | $16K |
| Ramipril | 15 | $15K |
| Insulin Glargine,hum.Rec.Anlog | 17 | $15K |
Prescribing Profile
Patient Profile
77
Avg Age
54%
Female
1.28
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About